Tempus, Intermountain to collaborate on oncology research

LabPulse.com staff writers
Jun 16, 2022
2019 05 22 19 44 5254 Dna Red Laser 400

Artificial intelligence (AI) developer Tempus and Intermountain Healthcare plan to collaborate on oncology research using genomic testing and data analytics.

Intermountain will use Tempus's solid tumor/normal genomic test, xT, to generate RNA data from existing transcriptomic samples; the RNA data will be matched with DNA data and used for oncology research, according to Tempus.

Latest in Artificial Intelligence
Artificial Intelligence Ai Binary Code Social
AI-powered endoscope doubles detection of high-risk esophageal lesions
April 17, 2024
Pharmaceutical Artificial Intelligence Social
Researchers design AI model to generate new antibiotics
April 9, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Computer Brain Money Social
Protein design firm Profluent raises $35M in funding
March 25, 2024
Related Stories
Colon2 Social
Companion Diagnostics
Tempus granted FDA premarket approval for colorectal cancer CDx
Sequencing Dna Rna Social
Product Launch
Curio Bioscience emerges from stealth mode with whole-transcriptome spatial mapping kit
Cancer Cell Microenvironment Social
Companion Diagnostics
Tempus, Kartos Therapeutics collaborate on CDx for Merkel cell carcinoma treatment
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Artificial Intelligence
AI-powered endoscope doubles detection of high-risk esophageal lesions
By Nick Paul Taylor
Deep learning has doubled the detection of high-risk lesions during routine endoscopies in a clinical trial of more than 3,000 patients in China.
April 17, 2024
Artificial Intelligence Ai Binary Code Social
Researchers design AI model to generate new antibiotics
By LabPulse.com staff writers
Researchers have devised an artificial intelligence (AI) model to develop potential new antibiotics which chemists can synthesize in the lab.
April 9, 2024
Pharmaceutical Artificial Intelligence Social
Ibex presents new study data for AI-powered cancer diagnostics platform
By Matt Limb
Ibex Medical Analytics is hailing positive data from studies with U.S. partners on the impact of its artificial intelligence (AI)-powered cancer diagnostic platform Galen.
March 26, 2024
Artificial Intelligence Ai Hand Social
Protein design firm Profluent raises $35M in funding
By LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
Computer Brain Money Social
AI foundation models set new benchmarks in computational pathology
By Nick Paul Taylor
Mass General Brigham researchers have published a pair of papers on artificial intelligence (AI) systems that could improve tasks that include the analysis of pathology images and identification of rare diseases.
March 20, 2024
Ai Woman Social
Machine-learning model predicts lung and liver cancer through genome sequence changes
By LabPulse.com staff writers
Researchers have developed a machine-learning approach that may potentially predict early-stage lung or liver cancer by detecting repetitive sequences in the genome.
March 15, 2024
Artificial Intelligence Lung Color Social
Zephyr AI closes $111M series A funding round
By LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
Artificial Intelligence Drug Design Funding Social
Predictive AI model might aid early-stage NSCLC planning
By Liz Carey
The deep-learning AI model identified features that were not readily discernable to a trained pathologist.
March 12, 2024
Cancer Lung 3 D Black Social
Study: AI assists discovery of prostate cancer subtypes
By Matt Limb
Prostate tumors have been found to evolve along multiple pathways, leading to two distinct disease types with “pivotal” implications for diagnosis and treatment, say scientists.
March 8, 2024
3 D Prostate Cancer Viral Social
Ibex, PathPresenter ink partnership
By LabPulse.com staff writers
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.
March 6, 2024
Hands Shaking2 Social
EnsoData’s AI-powered sleep study diagnostic gets FDA 510(k) clearance
By LabPulse.com staff writers
EnsoData has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its machine learning-based diagnostic for sleep apnea and other sleep disorders that uses data from pulse oximetry devices.
February 26, 2024
Fda Button Social
Opentrons Labworks unveils AI-powered workflow tools
By Matt Limb
Lab automation and robotics firm Opentrons Labworks Inc has unveiled new tools intended to enhance the efficiency of research across genomics, proteomics, cell biology, and synthetic biology.
February 8, 2024
Artificial Intelligence Ai Hand Social
Page 1 of 17
Next Page